Evidence map›Paper›PMID 39539171›Full record

ArticleThe Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology2025

Retinoic acid ameliorates rheumatoid arthritis by attenuating inflammation and modulating macrophage polarization through MKP-1/MAPK signaling pathway.

Mengyuan Xin, Hangyu Jin, Xiangyu Guo, Liang Zhao, Xiangdan Li, Dongyuan Xu, Long Zheng, Lan Liu

Abstract read
In one paragraph

Article in The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. The Application Prospects and Future Outlook ofDrug design, development and therapy · 2026
    Review
  4. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Mengyuan XinCenter of Morphological Experiment, Medical College of Yanbian University, Yanji 133002, Jilin, China.
Hangyu JinGrade 2022 College Students Major in Clinical Medicine, College of Medicine, Yanbian University, Yanji 133002, Jilin, China.
Xiangyu GuoCenter of Morphological Experiment, Medical College of Yanbian University, Yanji 133002, Jilin, China.
Liang ZhaoDepartment of Orthopedic Surgery, Yanbian University Hospital, Yanji 133002, Jilin, China.
Xiangdan LiCenter of Morphological Experiment, Medical College of Yanbian University, Yanji 133002, Jilin, China.
Dongyuan XuCenter of Morphological Experiment, Medical College of Yanbian University, Yanji 133002, Jilin, China.
Long ZhengDepartment of Orthopedic Surgery, Yanbian University Hospital, Yanji 133002, Jilin, China.
Lan LiuDepartment of Pathology, Yanbian University Hospital, Yanji 133002, Jilin, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Macrophages are innate immune cells connected with the development of inflammation. Retinoic acid has previously been proved to have anti-inflammatory and anti-arthritic properties. However, the exact mechanism through which retinoic acid modulates arthritis remains unclear. This study aimed to investigate whether retinoic acid ameliorates rheumatoid arthritis by modulating macrophage polarization. This study used retinoic acid to treat mice with adjuvant arthritis and evaluated anti-inflammatory effects by arthritis score, thermal nociceptive sensitization test, histopathologic examination and immunofluorescence assays. In addition, its specific anti-arthritic mechanism was investigated by flow cytometry, cell transfection and inflammatory signaling pathway assays in RAW264.7 macrophages

Indexed as

Adjuvant arthritisDual specificity phosphatase 1InflammationMacrophage activationTretinoin

Identifiers

PMID39539171
PMCPMC11694008

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.